203 related articles for article (PubMed ID: 26383516)
1. UNTREATED IRIS MELANOMA COMPLICATED BY HYPHEMA AND UNCONTROLLED GLAUCOMA RESPONSIVE TO IODINE-125 BRACHYTHERAPY.
Chang MY; McCannel CA; McCannel TA
Retin Cases Brief Rep; 2016; 10(1):44-7. PubMed ID: 26383516
[TBL] [Abstract][Full Text] [Related]
2. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
3. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy for recurrent hyphema after proton beam radiotherapy of iris melanoma.
Trichopoulos N; Damato B
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1573-5. PubMed ID: 17429673
[TBL] [Abstract][Full Text] [Related]
5. Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy.
Gray ME; Corrêa ZM; Augsburger JJ; Barrett W
Int Ophthalmol; 2007 Aug; 27(4):273-6. PubMed ID: 17468833
[TBL] [Abstract][Full Text] [Related]
6. [The analysis of I125 brachytherapy complications in cases of uveal melanoma].
Pogrzebielski A; Starzycka M; Romanowska-Dixon B; Jakubowska B; Szpakowicz U
Klin Oczna; 2005; 107(1-3):49-53. PubMed ID: 16052800
[TBL] [Abstract][Full Text] [Related]
7. Regression Patterns of Iris Melanoma after Palladium-103 (
Chaugule SS; Finger PT
Ophthalmology; 2017 Jul; 124(7):1023-1030. PubMed ID: 28377036
[TBL] [Abstract][Full Text] [Related]
8. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
[TBL] [Abstract][Full Text] [Related]
10. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
[TBL] [Abstract][Full Text] [Related]
11. Multifocal iris melanoma in a 2-year-old managed with I-125 plaque brachytherapy.
Lee AR; Grewal DS; Cummings TJ; Enyedi LB; Larrier NA; Mruthyunjaya P
J AAPOS; 2017 Oct; 21(5):410-412. PubMed ID: 28844752
[TBL] [Abstract][Full Text] [Related]
12. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
[TBL] [Abstract][Full Text] [Related]
13. Melanomalytic glaucoma secondary to iris melanoma.
Ajamil Rodanés S; García-Álvarez C; Saornil Alvarez MA; López-Lara F; Frutos Baraja JM; Quiñones M
Arch Soc Esp Oftalmol; 2017 Aug; 92(8):379-381. PubMed ID: 27746064
[TBL] [Abstract][Full Text] [Related]
14. Palladium-103 plaque radiation therapy for ciliary body melanoma through a functioning glaucoma filtering bleb.
Pathan AHK; Barash A; Tena LB; Finger PT
Eur J Ophthalmol; 2018 Jan; 28(1):119-122. PubMed ID: 28967074
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound biomicroscopy features of iris and ciliary body melanomas before and after brachytherapy.
Torres VL; Allemann N; Erwenne CM
Ophthalmic Surg Lasers Imaging; 2005; 36(2):129-38. PubMed ID: 15792314
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium plaque radiation for iris and iridociliary melanomas: development of dry eyes?
Razzaq L; de Keizer RJ
Br J Ophthalmol; 2010 Nov; 94(11):1549-50. PubMed ID: 20516146
[No Abstract] [Full Text] [Related]
17. Iris cavernous hemangioma in a patient with recurrent hyphema.
Lam S
Can J Ophthalmol; 1993 Feb; 28(1):36-9. PubMed ID: 8439863
[TBL] [Abstract][Full Text] [Related]
18. [Melanoma of the iris with recurrent hyphema--course over 32 years].
Schmidbauer JM; Burk RO; Daus W; Völcker HE
Klin Monbl Augenheilkd; 1993 Aug; 203(2):117-20. PubMed ID: 8231044
[TBL] [Abstract][Full Text] [Related]
19. Red laser cyclophotocoagulation in the treatment of secondary glaucoma in eyes with uveal melanoma.
Piirtola A; Puska P; Kivelä T
J Glaucoma; 2014 Jan; 23(1):50-5. PubMed ID: 22706337
[TBL] [Abstract][Full Text] [Related]
20. Conservative management of suspicious melanocytic lesions of the iris.
Oxenreiter MM; Lane AM; Jain P; Kim IK; Gragoudas ES
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1319-1324. PubMed ID: 30919077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
